Table of Contents

• Michael N. Cook,
• Cynthia J. Girman,
• Peter P. Stein,
• Charles M. Alexander,
• and Rury R. Holman

Glycemic Control Continues to Deteriorate After Sulfonylureas Are Added to Metformin Among Patients With Type 2 Diabetes

• Lawrence S. Cozma,
• Stephen D. Luzio,
• Gareth J. Dunseath,
• Paul M. Underwood,
• and David R. Owens

β-Cell Response During a Meal Test: A comparative study of incremental doses of repaglinide in type 2 diabetic patients

• David Baldwin,
• Griselda Villanueva,
• Robert McNutt,
• and Sarika Bhatnagar

Eliminating Inpatient Sliding-Scale Insulin: A reeducation project with medical house staff

• Anjali D. Deshpande,
• Elizabeth A. Baker,
• Sarah L. Lovegreen,
• and Ross C. Brownson

Environmental Correlates of Physical Activity Among Individuals With Diabetes in the Rural Midwest

• Vijay Viswanathan,
• Sivagami Madhavan,
• Seena Rajasekar,
• Snehalatha Chamukuttan,
• and Ramachandran Ambady

Amputation Prevention Initiative in South India: Positive impact of foot care education

• Lu Qi,
• Eric Rimm,
• Simin Liu,
• Nader Rifai,
• and Frank B. Hu

Dietary Glycemic Index, Glycemic Load, Cereal Fiber, and Plasma Adiponectin Concentration in Diabetic Men

• Amanda G. Kennedy,
• Charles D. MacLean,
• Benjamin Littenberg,
• Philip A. Ades,
• and Richard G. Pinckney

The Challenge of Achieving National Cholesterol Goals in Patients With Diabetes

• Katherine Esposito,
• Francesco Giugliano,
• Emilia Martedì,
• Giovanni Feola,
• Raffaele Marfella,
• Massimo D’Armiento,
• and Dario Giugliano

High Proportions of Erectile Dysfunction in Men With the Metabolic Syndrome

• Marceline Huppmann,
• Andrea Baumgarten,
• Anette-G. Ziegler,
• and Ezio Bonifacio

Neonatal Bacille Calmette-Guerin Vaccination and Type 1 Diabetes

• Karen V. Smirnakis,
• Abelardo Martinez,
• Karen Hsu Blatman,
• Myles Wolf,
• Jeffrey L. Ecker,
• and Ravi Thadhani

Early Pregnancy Insulin Resistance and Subsequent Gestational Diabetes Mellitus

• Gareth R. Dutton,
• Jolene Johnson,
• Dori Whitehead,
• Jamie S. Bodenlos,
• and Phillip J. Brantley

Barriers to Physical Activity Among Predominantly Low-Income African- American Patients With Type 2 Diabetes

• Sharon H. Saydah,
• Anjani Chandra,
• and Mark S. Eberhardt

Pregnancy Experience Among Women With and Without Gestational Diabetes in the U.S., 1995 National Survey of Family Growth

• Nilka Ríos Burrows,
• Andrew S. Narva,
• Linda S. Geiss,
• Michael M. Engelgau,
• and Kelly J. Acton

End-Stage Renal Disease due to Diabetes Among Southwestern American Indians, 1990–2001

• Gillian L. Booth,
• Janet E. Hux,
• Jiming Fang,
• and Benjamin T.B. Chan

Time Trends and Geographic Disparities in Acute Complications of Diabetes in Ontario, Canada

• R. Paul Wadwa,
• Gregory L. Kinney,
• David M. Maahs,
• Janet Snell-Bergeon,
• John E. Hokanson,
• Satish K. Garg,
• Robert H. Eckel,
• and Marian Rewers

Awareness and Treatment of Dyslipidemia in Young Adults With Type 1 Diabetes

• Kiang Liu,
• Alan R. Dyer,
• Thanh-Huyen Vu,
• Amber Pirzada,
• Larry M. Manheim,
• Willard G. Manning,
• Muhammad S. Ashraf,
• Daniel B. Garside,
• and Martha L. Daviglus

One-Hour Postload Plasma Glucose in Middle Age and Medicare Expenditures in Older Age Among Nondiabetic Men and Women: The Chicago Heart Association Detection Project in Industry

• Lauren C. Brown,
• Sumit R. Majumdar,
• Stephen C. Newman,
• and Jeffrey A. Johnson

History of Depression Increases Risk of Type 2 Diabetes in Younger Adults

• Yasufumi Doi,
• Yutaka Kiyohara,
• Michiaki Kubo,
• Yumihiro Tanizaki,
• Ken Okubo,
• Toshiharu Ninomiya,
• Masanori Iwase,
• and Mitsuo Iida

Relationship Between C-Reactive Protein and Glucose Levels in Community-Dwelling Subjects Without Diabetes: The Hisayama Study

Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes: The Diabetes Prevention Trial–Type 1

• Klaus Rave,
• Susanne Bott,
• Lutz Heinemann,
• Sue Sha,
• Reinhard H.A. Becker,
• Susan A. Willavize,
• and Tim Heise

Time-Action Profile of Inhaled Insulin in Comparison With Subcutaneously Injected Insulin Lispro and Regular Human Insulin

• David M. Kendall,
• Matthew C. Riddle,
• Julio Rosenstock,
• Dongliang Zhuang,
• Dennis D. Kim,
• Mark S. Fineman,
• and Alain D. Baron

Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea

• Ralph A. DeFronzo,
• Robert E. Ratner,
• Jenny Han,
• Dennis D. Kim,
• Mark S. Fineman,
• and Alain D. Baron

Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes

A Randomized Multicenter Trial Comparing the GlucoWatch Biographer With Standard Glucose Monitoring in Children With Type 1 Diabetes

• Johannes Plank,
• Manfred Bodenlenz,
• Frank Sinner,
• Christoph Magnes,
• Evelyn Görzer,
• Werner Regittnig,
• Lars A. Endahl,
• Eberhard Draeger,
• Milan Zdravkovic,
• and Thomas R. Pieber

A Double-Blind, Randomized, Dose-Response Study Investigating the Pharmacodynamic and Pharmacokinetic Properties of the Long-Acting Insulin Analog Detemir

• Dario Pitocco,
• Valeria Ruotolo,
• Salvatore Caputo,
• Lorena Mancini,
• Chiara M. Collina,
• Andrea Manto,
• Paolo Caradonna,
• and Giovanni Ghirlanda

Six-Month Treatment With Alendronate in Acute Charcot Neuroarthropathy: A randomized controlled trial

• Lois Jovanovic,
• Robert H. Knopp,
• Haesook Kim,
• William T. Cefalu,
• Xiao-Dong Zhu,
• Young Jack Lee,
• Joe Leigh Simpson,
• and James L. Mills

Elevated Pregnancy Losses at High and Low Extremes of Maternal Glucose in Early Normal and Diabetic Pregnancy: Evidence for a protective adaptation in diabetes

• Kathrine J. Craig,
• John D. Williams,
• Stephen G. Riley,
• Hilary Smith,
• David R. Owens,
• Debbie Worthing,
• Ivor Cavill,
• and Aled O. Phillips

Anemia and Diabetes in the Absence of Nephropathy

• Niyaz R. Gosmanov,
• Ervin Szoke,
• Zarmen Israelian,
• Tamar Smith,
• Philip E. Cryer,
• John E. Gerich,
• and Christian Meyer

Role of the Decrement in Intraislet Insulin for the Glucagon Response to Hypoglycemia in Humans

• Andrea Mari,
• Amalia Gastaldelli,
• James E. Foley,
• Richard E. Pratley,
• and Ele Ferrannini

β-Cell Function in Mild Type 2 Diabetic Patients: Effects of 6-month glucose lowering with nateglinide

• Eun Seok Kang,
• So Young Park,
• Hyeong Jin Kim,
• Chul Woo Ahn,
• Moonsuk Nam,
• Bong Soo Cha,
• Sung Kil Lim,
• Kyung Rae Kim,
• and Hyun Chul Lee

The Influence of Adiponectin Gene Polymorphism on the Rosiglitazone Response in Patients With Type 2 Diabetes

• Graham T. McMahon,
• Jorge Plutzky,
• Edouard Daher,
• Tammy Bhattacharyya,
• George Grunberger,
• and Marcelo F. DiCarli

Effect of a Peroxisome Proliferator–Activated Receptor-γ Agonist on Myocardial Blood Flow in Type 2 Diabetes

• Peter S. Sever,
• Neil R. Poulter,
• Björn Dahlöf,
• Hans Wedel,
• Rory Collins,
• Gareth Beevers,
• Mark Caulfield,
• Sverre E. Kjeldsen,
• Arni Kristinsson,
• Gordon T. McInnes,
• Jesper Mehlsen,
• Markku Nieminen,
• Eoin O’Brien,
• and Jan Ostergren

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid-Lowering Arm (ASCOT-LLA)

• Sophie Bernard,
• André Sérusclat,
• François Targe,
• Sybil Charrière,
• Olivier Roth,
• Jacques Beaune,
• François Berthezène,
• and Philippe Moulin

Incremental Predictive Value of Carotid Ultrasonography in the Assessment of Coronary Risk in a Cohort of Asymptomatic Type 2 Diabetic Subjects

• D. Michael Hallman,
• J. Charles Huber, Jr.,
• Victor H. Gonzalez,
• Barbara E.K. Klein,
• Ronald Klein,
• and Craig L. Hanis

Familial Aggregation of Severity of Diabetic Retinopathy in Mexican Americans From Starr County, Texas

• Dan Ziegler,
• Ewa Siekierka-Kleiser,
• Bernd Meyer,
• and Michael Schweers

Validation of a Novel Screening Device (NeuroQuick) for Quantitative Assessment of Small Nerve Fiber Dysfunction as an Early Feature of Diabetic Polyneuropathy

• Milagros G. Huerta,
• James N. Roemmich,
• Marit L. Kington,
• Viktor E. Bovbjerg,
• Arthur L. Weltman,
• Viola F. Holmes,
• James T. Patrie,
• Alan D. Rogol,
• and Jerry L. Nadler

Magnesium Deficiency Is Associated With Insulin Resistance in Obese Children

• Siobhan McQuaid,
• Donal J. O’Gorman,
• Obada Yousif,
• Toh Peng Yeow,
• Yusof Rahman,
• Declan Gasparro,
• Giovanni Pacini,
• and John J Nolan

Early-Onset Insulin-Resistant Diabetes in Obese Caucasians Has Features of Typical Type 2 Diabetes, but 3 Decades Earlier

• Neslihan Gungor,
• Trina Thompson,
• Kim Sutton-Tyrrell,
• Janine Janosky,
• and Silva Arslanian

Early Signs of Cardiovascular Disease in Youth With Obesity and Type 2 Diabetes

• Koichi Hashimoto,
• Katsunori Ikewaki,
• Hidenori Yagi,
• Hidetaka Nagasawa,
• Satoshi Imamoto,
• Takahiro Shibata,
• and Seibu Mochizuki

Glucose Intolerance Is Common in Japanese Patients With Acute Coronary Syndrome Who Were Not Previously Diagnosed With Diabetes

• Monica Franciosi,
• Giorgia De Berardis,
• Maria C.E. Rossi,
• Michele Sacco,
• Maurizio Belfiglio,
• Fabio Pellegrini,
• Gianni Tognoni,
• Miriam Valentini,
• and Antonio Nicolucci

Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance: The IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study

• Ulf Ekelund,
• Søren Brage,
• Paul W. Franks,
• Susie Hennings,
• Sue Emms,
• and Nicholas J. Wareham

Physical Activity Energy Expenditure Predicts Progression Toward the Metabolic Syndrome Independently of Aerobic Fitness in Middle-Aged Healthy Caucasians: The Medical Research Council Ely Study

• Marno C. Ryan,
• Andrew M. Wilson,
• John Slavin,
• James D. Best,
• Alicia J. Jenkins,
• and Paul V. Desmond

Associations Between Liver Histology and Severity of the Metabolic Syndrome in Subjects With Nonalcoholic Fatty Liver Disease

• Christophe Binnert,
• Myriam Genoud,
• Gérald Seematter,
• Assia Fekirini,
• Vincent Mooser,
• Gérard Waeber,
• and Luc Tappy

Glucose-Induced Insulin Secretion in Dyslipidemic and Normolipidemic Patients With Normal Glucose Tolerance

• Earl S. Ford,
• Umed A. Ajani,
• Lisa C. McGuire,
• and Simin Liu

Concentrations of Serum Vitamin D and the Metabolic Syndrome Among U.S. Adults

• David C. Klonoff

Continuous Glucose Monitoring: Roadmap for 21st century diabetes therapy

• Elaine Cochran,
• Carla Musso,
• and Phillip Gorden

The Use of U-500 in Patients With Extreme Insulin Resistance

Defining and Reporting Hypoglycemia in Diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia

• Zachary T. Bloomgarden

The European Association for the Study of Diabetes

• Sindhu S. Jacob,
• Sony Jacob,
• Craig Williams,
• and Mark A. Deeg

Simvastatin, Fenofibrate, and Rhabdomyolysis

• Shane R. Reti,
• Felicity A. Goodyear-Smith,
• and Ross I. McCormick

Self-Reported Diabetes in Northland, New Zealand

• Vijay Viswanathan,
• Mamtha B. Nair,
• Sheethal Suresh,
• Snehalatha Chamukuttan,
• and Ramachandran Ambady

An Inexpensive Method to Diagnose Incipient Diabetic Nephropathy in Developing Countries

• Aidan McElduff,
• Glynis P. Ross,
• Janet A. Lagström,
• Bernard Champion,
• Jeff R. Flack,
• Sue-Mei Lau,
• Robert G. Moses,
• Sivanthi Seneratne,
• Mark McLean,
• and N. Wah Cheung

Pregestational Diabetes and Pregnancy: An Australian experience

• Daniel Öberg and
• Claes-Göran Östenson

Performance of Glucose Dehydrogenase–and Glucose Oxidase–Based Blood Glucose Meters at High Altitude and Low Temperature

• Kamal I. Hirbli,
• Mayssa A. Jambeine,
• Hanna B. Slim,
• Wadad M. Barakat,
• Richard J. Habis,
• and Zelia M. Francis

Prevalence of Diabetes in Greater Beirut

• Arrigo F.G. Cicero,
• Antonio V. Gaddi,
• and Giuseppe Derosa

Two-Year Statin Therapy Does Not Alter the Progression of Intima-Media Thickness in Patients With Type 2 Diabetes Without Manifest Cardio-vascular Disease: Response to Beishuizen et al.

• Edith D. Beishuizen,
• Marcel A. van de Ree,
• J. Wouter Jukema,
• Jouke T. Tamsma,
• and Menno V. Huisman

Two-Year Statin Therapy Does Not Alter the Progression of Intima-Media Thickness in Patients With Type 2 Diabetes Without Manifest Cardio-vascular Disease: Response to Cicero et al.

• Matthias B. Schulze and
• Kurt Hoffmann

Is Atherosclerosis in Diabetes and Impaired Fasting Glucose Driven by Elevated LDL Cholesterol or by Decreased HDL Cholesterol?: Response to Drexel et al.

• Heinz Drexel,
• Stefan Aczel,
• Thomas Marte,
• Werner Benzer,
• Peter Langer,
• Willi Moll,
• and Christoph H. Saely

Is Atherosclerosis in Diabetes and Impaired Fasting Glucose Driven by Elevated LDL Cholesterol or by Decreased HDL Cholesterol?: Response to Schulze and Hoffmann

• Frans Pouwer and
• Peter de Jonge

Depressive Symptoms, Insulin Resistance, and Risk of Diabetes in Women at Midlife: Response to Everson-Rose et al.

• Susan A. Everson-Rose,
• Karen A. Matthews,
• Javier I. Torréns,
• Joyce T. Bromberger,
• Howard M. Kravitz,
• and Peter M. Meyer

Depressive Symptoms, Insulin Resistance, and Risk of Diabetes in Women at Midlife: Response to Pouwer and de Jonge

• Tsung-Hsueh Lu,
• Pei-Yuen Hsu,
• Robert N. Anderson,
• and Chien-Ning Huang

Mortality and Causes of Death in a National Sample of Diabetic Patients in Taiwan: Response to Tseng

• Chin-Hsiao Tseng

Mortality and Causes of Death in a National Sample of Diabetic Patients in Taiwan: Response to Lu et al.

Erratum